Bill

Bill > HB324


OH HB324

OH HB324
Enact the Patient Protection Act


summary

Introduced
06/03/2025
In Committee
11/19/2025
Crossed Over
11/19/2025
Passed
Dead

Introduced Session

136th General Assembly

Bill Summary

To enact section 3715.39 of the Revised Code to establish conditions on the prescribing of prescription drugs causing severe adverse effects and to name this act the Patient Protection Act.

AI Summary

This bill establishes new requirements for prescribing dangerous drugs with severe adverse effects in Ohio. The bill defines "severe adverse effects" as including death, hospitalization-requiring infections or hemorrhaging, organ failure, and sepsis. Before prescribing a drug that causes severe adverse effects in more than 5% of users, healthcare providers must conduct an in-person patient examination, explicitly inform the patient about the potential severe side effects, and schedule a follow-up appointment. The Ohio Director of Health will be responsible for determining which drugs meet the 5% severe adverse effect threshold, consulting with the insurance superintendent and executives from the state pharmacy and medical boards. The director will use insurance claims, patient reports, and FDA data to compile and publicly update a list of drugs with significant adverse effect risks. The bill specifically excludes veterinarians from the prescriber definition and is officially named the "Patient Protection Act". The goal appears to be increasing patient awareness and medical oversight for potentially dangerous medications by mandating more comprehensive informed consent and follow-up procedures.

Committee Categories

Health and Social Services

Sponsors (23)

Last Action

Referred to committee: Health (on 02/11/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...